NephrAmine |
HUMAN PRESCRIPTION DRUG LABEL |
10 |
0264-1909 |
INJECTION, SOLUTION |
0.56 g |
INTRAVENOUS |
NDA |
13 sections
|
ProcalAmine |
HUMAN PRESCRIPTION DRUG LABEL |
22 |
0264-1915 |
INJECTION |
0.21 g |
INTRAVENOUS |
NDA |
13 sections
|
Plenamine |
HUMAN PRESCRIPTION DRUG LABEL |
17 |
0264-3200 |
SOLUTION |
749 mg |
INTRAVENOUS |
ANDA |
13 sections
|
Plenamine |
HUMAN PRESCRIPTION DRUG LABEL |
17 |
0264-3205 |
SOLUTION |
749 mg |
INTRAVENOUS |
ANDA |
13 sections
|
Plenamine |
HUMAN PRESCRIPTION DRUG LABEL |
17 |
0264-4500 |
SOLUTION |
749 mg |
INTRAVENOUS |
ANDA |
13 sections
|
FreAmine III |
HUMAN PRESCRIPTION DRUG LABEL |
16 |
0264-9010 |
INJECTION, SOLUTION |
0.69 g |
INTRAVENOUS |
NDA |
13 sections
|
FreAmine III |
HUMAN PRESCRIPTION DRUG LABEL |
16 |
0264-9011 |
INJECTION, SOLUTION |
0.69 g |
INTRAVENOUS |
NDA |
13 sections
|
TrophAmine |
HUMAN PRESCRIPTION DRUG LABEL |
20 |
0264-9341 |
SOLUTION |
0.82 g |
INTRAVENOUS |
NDA |
12 sections
|
FreAmine HBC |
HUMAN PRESCRIPTION DRUG LABEL |
15 |
0264-9350 |
INJECTION, SOLUTION |
0.76 g |
INTRAVENOUS |
NDA |
13 sections
|
TrophAmine |
HUMAN PRESCRIPTION DRUG LABEL |
20 |
0264-9361 |
SOLUTION |
0.49 g |
INTRAVENOUS |
NDA |
12 sections
|
HepatAmine |
HUMAN PRESCRIPTION DRUG LABEL |
16 |
0264-9371 |
INJECTION, SOLUTION |
0.90 g |
INTRAVENOUS |
NDA |
13 sections
|
ProSol |
HUMAN PRESCRIPTION DRUG LABEL |
17 |
0338-0499 |
INJECTION, SOLUTION |
1.08 g |
INTRAVENOUS |
NDA |
15 sections
|
Clinisol |
HUMAN PRESCRIPTION DRUG LABEL |
17 |
0338-0502 |
INJECTION, SOLUTION |
749 mg |
INTRAVENOUS |
ANDA |
11 sections
|
Travasol |
HUMAN PRESCRIPTION DRUG LABEL |
15 |
0338-0644 |
INJECTION |
600 mg |
INTRAVENOUS |
NDA |
15 sections
|
CLINIMIX |
HUMAN PRESCRIPTION DRUG LABEL |
16 |
0338-1083 |
INJECTION |
165 mg |
INTRAVENOUS |
NDA |
14 sections
|
CLINIMIX |
HUMAN PRESCRIPTION DRUG LABEL |
16 |
0338-1089 |
INJECTION |
255 mg |
INTRAVENOUS |
NDA |
14 sections
|
CLINIMIX |
HUMAN PRESCRIPTION DRUG LABEL |
16 |
0338-1091 |
INJECTION |
255 mg |
INTRAVENOUS |
NDA |
14 sections
|
CLINIMIX |
HUMAN PRESCRIPTION DRUG LABEL |
16 |
0338-1093 |
INJECTION |
255 mg |
INTRAVENOUS |
NDA |
14 sections
|
CLINIMIX |
HUMAN PRESCRIPTION DRUG LABEL |
16 |
0338-1095 |
INJECTION |
255 mg |
INTRAVENOUS |
NDA |
14 sections
|
CLINIMIX |
HUMAN PRESCRIPTION DRUG LABEL |
16 |
0338-1099 |
INJECTION |
300 mg |
INTRAVENOUS |
NDA |
14 sections
|
CLINIMIX |
HUMAN PRESCRIPTION DRUG LABEL |
16 |
0338-1101 |
INJECTION |
300 mg |
INTRAVENOUS |
NDA |
14 sections
|
CLINIMIX |
HUMAN PRESCRIPTION DRUG LABEL |
15 |
0338-1103 |
INJECTION |
300 mg |
INTRAVENOUS |
NDA |
14 sections
|
CLINIMIX E |
HUMAN PRESCRIPTION DRUG LABEL |
21 |
0338-1107 |
INJECTION |
165 mg |
INTRAVENOUS |
NDA |
16 sections
|
CLINIMIX E |
HUMAN PRESCRIPTION DRUG LABEL |
21 |
0338-1109 |
INJECTION |
165 mg |
INTRAVENOUS |
NDA |
16 sections
|
CLINIMIX E |
HUMAN PRESCRIPTION DRUG LABEL |
21 |
0338-1113 |
INJECTION |
255 mg |
INTRAVENOUS |
NDA |
16 sections
|
CLINIMIX E |
HUMAN PRESCRIPTION DRUG LABEL |
21 |
0338-1115 |
INJECTION |
255 mg |
INTRAVENOUS |
NDA |
16 sections
|
CLINIMIX E |
HUMAN PRESCRIPTION DRUG LABEL |
21 |
0338-1119 |
INJECTION |
255 mg |
INTRAVENOUS |
NDA |
16 sections
|
CLINIMIX E |
HUMAN PRESCRIPTION DRUG LABEL |
21 |
0338-1123 |
INJECTION |
300 mg |
INTRAVENOUS |
NDA |
16 sections
|
CLINIMIX E |
HUMAN PRESCRIPTION DRUG LABEL |
21 |
0338-1125 |
INJECTION |
300 mg |
INTRAVENOUS |
NDA |
16 sections
|
CLINIMIX E |
HUMAN PRESCRIPTION DRUG LABEL |
21 |
0338-1127 |
INJECTION |
300 mg |
INTRAVENOUS |
NDA |
16 sections
|